FDA approves subcutaneous Vyvgart Hytrulo for generalized myasthenia gravis
The U.S. Food and Drug Administration has approved Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) subcutaneous injections for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine ...
Jun 28, 2023
0
2